This diagram was made using Edrawmax. The poster presented by Paulina Panasiuk from the Molecular Biotechnology Department of Jagiellonian University, investigates the therapeutic effects of Cyclic Glycine-Proline (cGP) on Alzheimer's disease (AD) mice models. The abstract summarizes the study's objective: exploring cGP's potential in mitigating memory deficits and reducing amyloid plaque accumulation, hallmarks of Alzheimer's pathology. Through experiments using the APP/PS1 transgenic mouse model, it shows that cGP treatment significantly improves spatial memory performance and reduces amyloid plaque burden, indicating cGP's potential as a candidate for AD treatment. The results section includes bar graphs and Morris water maze tests, illustrating improved memory function and navigation efficiency in cGP-treated mice compared to untreated ones. The findings suggest cGP as a promising substance for AD interventions, with the visual data supporting the textual conclusions.